A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: The optimal duration of therapy

Chest

Volumn 110, Issue 4, 1996, Pages 965-971

  Siegel, Robert E ^a,c   Halpern, Neil A ^a,c   Almenoff, Peter L ^a,c   Lee, Alice ^a   Cashin, Robert ^a   Greene, Jerry G ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotic; community acquired pneumonia; cost; length of stay

Indexed keywords

CEFUROXIME; CEFUROXIME AXETIL;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029995677     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.965     Document Type: Article

References (36)

1. Grasela TH Jr, Welage LS, Walawander CA, et al. A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. DICP Ann Pharmacother 1990; 24:1220-25
2. American Hospital Association. Hospital statistics, 1993-4 edition. Chicago: American Hospital Association, 1994
3. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-26
4. McGhee JL, Podnos SD, Pierce AK, et al. Treatment of pneumonia in patients at risk of infection with Gram-negative bacilli. Am J Med 1988; 84:597-602
5. Kahn FA, Basir R. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 1989; 96:528-37
6. Ehrenkranz NJ, Nerenberg DE, Shultz JM, et al. Intervention to discontinue parenteral antimicrobial therapy in patients hospitalized with pulmonary infection: effect on shortening patient stay. Infect Control Hosp Epidemiol 1992; 13:21-32
7. Quintiliani R, Cooper BW, Briceland LL, et al. Economic impact of streamlining antibiotic administration. Am J Med 1987; 82(suppl 4A):391-94
8. NCCLS. Performance standards for antimicrobial disk susceptibility tests. 5th ed. Approved standard. NCCLS document M2-A5 (ISBN 1-56238-208-X). Villanova, Pa: National Committee for Clinical Laboratory Standards, 1993
9. Detsky AS, Sackett DL. When was a 'negative' clinical trial big enough? Arch Intern Med 1985; 145:709-12
10. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum, 1988
11. Beattle MC, Swindel RW, Tomko LA, et al. Patient treatment file. Palo Alto, Calif: HSR&D Center for Health Care Evaluation, Department of Veterans Affairs Medical Center, 1993
12. Public Health Service and Health Care Financing Administration. International classification of diseases, 9th revision, clinical modification. 3rd ed. Washington, DC: Public Health Service, 1989
13. Cost distribution report, RCS 10-0141, medical care appropriations, total all station, fiscal year 1994. Austin, Tex: Austin Automation Center, Department of Veterans Affairs, 1994
14. Cost distribution report handbook for preparation of the cost distribution report Washington, DC: Department of Veterans Affairs Central Office, December 1989
15. Chapko MK, Ehreth JL, Hedrick S. Methods of determining the cost of health care in the Department of Veterans Affairs medical centers and other non-priced settings. Eval Health Professions 1991; 14:282-303
16. Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 1990; 89:713-21
17. Pareja A, Bernal C, Leyva A, et al. Etiologic study of patients with community-acquired pneumonia. Chest 1992; 101:1207-10
18. Fang G-D, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 1990; 69:307-16
19. Valcke Y, Pauwels R, Van Der Straeten M. Pharmacokinetics of antibiotics in the lungs. Eur Respir J 1990; 3:715-22
20. Pennington JE. Penetration of antibiotics into respirators secretions. Rev Infect Dis 1981; 3:67-73.
21. Barza M, Cuchural G. General principles of antibiotic tissue penetration. Antimicrob Agents Chemother 1985; 5(suppl A): 59-75
22. Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis 1978; 14(suppl):262-66
23. Stein GE, Mantz SL. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia. Hosp Pharm 1995; 30:132-34
24. Fine MJ, Singer DE, Banusa BH, et al. Validation of a pneumonia prognostic index using the medisgroups comparative hospital database. Am J Med 1993; 94:153-59
25. Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 1990; 89:713-21
26. Sanders EW, Morris JF, Alessi P, et al. Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with usual care in a multicenter clinical trial. Am J Med 1991; 91:261-66
27. Chan R, Hemeryck L, O'Regan M, et al. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. BMJ 1995; 310:1360-62
28. Ewald GA, McKenzie CR. Manual of medical therapeutics. 28th ed. Boston: Little Brown, 1995
29. Pennington JE. Respiratory infections diagnosis and management. 3rd ed. New York: Raven Press, 1994
30. Isselbacher KJ, Braunwald E, Wilson JD, et al. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994
31. Weingarten SR, Riedinger MS, Varis G, et al. Identification of low-risk hospitalized patients with pneumonia, implications for early conversion to oral therapy. Chest 1994; 105:1109-15
32. Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991; 91:462-70
33. Dagan R, Syrogiannopoulos G, Ashkenazi S, et al. Parenteral-oral switch in the management of paediatric pneumonia. Drugs 1994; 47(suppl 3): 43-51
34. Fine MJ, Singer DE, Phelps AL, et al. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care 1993; 31:371-80
35. Center for Disease Control and Prevention/National Center for Health Statistics. Vital and health statistics, detailed diagnoses and procedures, national hospital discharge survey, 1992. Hyattsville, Md: DHHS publication No. 94-1779, 1994
36. Health Services Cost Review Commission. Hospital discharge file. Baltimore: Maryland Department of Health and Mental Hygiene, 1994